+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Genomic aspects of sporadic Parkinson's disease



Genomic aspects of sporadic Parkinson's disease



Parkinsonism and Related Disorders 14(Suppl. 2): S88



Parkinson's disease (PD) is thought to be associated with oxidative stress mechanisms, as well as with glutamate receptor abnormalities, ubiquitin-proteasome dysfunction, inflammatory and cytokine activation, dysfunction in neurotrophic factors, damage to mitochondria, cytoskeletal abnormalities, synaptic dysfunction and activation of apoptotic pathways. To investigate these hypotheses, many researchers have applied molecular biology techniques to the study of neuronal cell death in these conditions. In this article, we discuss recent findings of gene expression in PD that may elucidate the usage of specific new biomarkers for sporadic PD and point to novel drug developments.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053398729

Download citation: RISBibTeXText

PMID: 18585078

DOI: 10.1016/j.parkreldis.2008.04.009


Related references

Association studies of sporadic Parkinson's disease in the genomic era. Current Genomics 15(1): 2-10, 2014

Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease. Journal of Neural Transmission. Supplementum 2000(60): 101-116, 2000

Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. Journal of Neural Transmission 118(5): 821-839, 2011

Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 70(5): 662-665, 2001

Genomic aspects of sporadic neurodegenerative diseases. Biochemical and Biophysical Research Communications 452(2): 221-225, 2014

An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease. Medicina Clinica 94(15): 585-595, 1990

Genetics of sporadic disease: insights from high-throughput sequencing --Parkinson disease. Rinsho Shinkeigaku 51(11): 973-974, 2011

An atypical case of sporadic Creutzfeldt-Jakob disease with Parkinson's disease. Neuropathology 21(4): 294-297, 2001

Mendelian genes for Parkinson's disease contribute to the sporadic forms of the disease. Human Molecular Genetics 24(7): 2023-2034, 2015

Alpha-2 macroglobulin I1000V polymorphism in Chinese sporadic Alzheimer's disease and Parkinson's disease. Neuroscience Letters 328(2): 195-197, 2002

A tangled web - tau and sporadic Parkinson's disease. Frontiers in Psychiatry 1: 150, 2010

Pathology associated with sporadic Parkinson's disease--where does it end?. Journal of Neural Transmission. Supplementum 2006(70): 89-97, 2006

Pathophysiology of sporadic Parkinson's disease. Fortschritte der Neurologie-Psychiatrie 78(Suppl. 1): S2-S4, 2010